All 2025 pre-filled syringe doses to be made in Canada, marking a domestic production milestone
This is the group’s first NoC approval in Canada
The approval is based on a comprehensive package of analytical, nonclinical, and clinical data
700 new scientific and high-skilled jobs to be created in Greater Toronto Area, investing to execute more than 210 AstraZeneca global clinical studies
The transaction is part of a broader agreement with Bureau Veritas covering its worldwide food laboratory testing activities
Akums Drugs will undertake this development and commercialization in India
eGenesis is pioneering a genome engineering-based approach in the development of safe and effective transplantable organs to end the global organ shortage
Biocon Biologics earlier announced a settlement agreement in the United States for a Bmab 1200 launch no later than February 22, 2025
Pegfilgrastim is a Pegylated form of the recombinant human granulocyte colony-stimulating factor (G-CSF) analogue Filgrastim
The transaction aligns with Lupin's strategy to grow its global presence in Specialty areas
Subscribe To Our Newsletter & Stay Updated
